Page 1425 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

33. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal 53. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for preven-
oxygenation. Effects of diuretics. Am J Physiol. 1994;267:F1059. tion of acute deterioration of renal function following elective
34. Venkatachalam MA, Bernard DB, Donohoe JF, et al. Ischemic coronary angiography and intervention: a randomized con-
damage and repair in the rat proximal tubule: differences trolled trial. JAMA. 2003;289:553.
among the S1, S2, and S3 segments. Kidney Int. 1978;14:31. 54. Baker CSR, Wragg A, Kumar S, et al. A rapid protocol for the
35. Patel R, McKenzie JK, McQueen EG. Tamm-Horsfall urinary prevention of contrast-induced renal dysfunction: the RAPPID
mucoprotein and tubular obstruction by casts in acute renal Study. J Am Coll Cardiol. 2003;41:2114.
failure. Lancet. 1964;1:457. 55. Durham JD, Caputo C, Dokko J, et al. A randomized controlled
36. Donohoe FJ, Venkatachalam MA, Bernard DB, et al. Tubular trial of N-acetylcysteine to prevent contrast nephropathy in
leakage and obstruction after renal ischemia: structure-function cardiac angiography. Kidney Int. 2002;62:2202.
correlations. Kidney Int. 1978;13:208. 56. Alonso A, et al. Prevention of radiocontrast nephropathy with
37. Myers BD, Chui F, Hilberman M, et al. Transtubular leakage of N-acetylcysteine in patients with chronic kidney disease: a meta-
glomerular filtrate in human acute renal failure. Am J Physiol. analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1.
1978;237:F319. 57. Hoffmann U, Fischereder M, Kruger B, et al. The value of
38. Moran SM, Myers BD. Pathophysiology of protracted acute N-acetylcysteine in the prevention of radiocontrast agent-
renal failure in man. J Clin Invest. 1985;76:1440. induced nephropathy seems questionable. J Am Soc Nephrol.
2004;15:407.
39. Matzke G, Lucarotti R, Shapiro HS. Controlled comparison of gen-
tamicin and tobramycin nephrotoxicity. Am J Nephrol. 1983;3:11. 58. Genet S, Kale RK, Baquer NZ. Effects of free radicals on
cytosolic creatinine kinase activities and protection by anti-
40. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice
daily gentamicin in patients with serious infections. Lancet. oxidant enzymes and sulfhydryl compounds. Mol Cell Biochem.
1993;341:335. 2000;210:23.
41. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing 59. ACT Investigators. Acetylcysteine for prevention of renal out-
in immunocompetent adults: a meta-analysis. Ann Intern Med. comes in patients undergoing coronary and peripheral vascular
1996;124:717. angiography. Circulation. 2011;124:1250-1259.
42. Barza M, et al. Single or multiple daily doses of aminoglyco- 60. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast
sides: a meta-analysis. Br Med J. 1996;312:338. nephropathy in patients with and without diabetes mellitus.
Kidney Int. 1994;45:259.
43. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contem-
porary definitions of contrast nephropathy in patients undergoing 61. Stone GW, et al. Fenoldopam mesylate for the prevention of
percutaneous coronary intervention and a proposal for a novel contrast-induced nephropathy: a randomized controlled trial.
nephropathy grading system. Am J Cardiol. 2008;101:812-819. JAMA. 2003;290:2284.
44. Rudnick MR, Berns JS, Cohen RM, et al. Contrast media- 62. Solomon R, Werner C, Mann D, et al. Effects of saline,
associated nephropathy. Semin Nephrol. 1997;17:15. mannitol, and furosemide on acute decreases in renal
function induced by radiocontrast agents. N Engl J Med.
45. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure 1994;331:1416.
after coronary intervention: incidence, risk factors, and rela-
tionship to mortality. Am J Med. 1997;103:368-375. 63. Lehnert T, Keller E, Gondolf K, et al. Effect of hemodialysis
after contrast media administration in patients with renal insuf-
46. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ficiency. Nephrol Dial Transplant. 1998;13:358.
ionic and nonionic contrast media in 1196 patients: a random-
ized trial. Kidney Int. 1995;47:254. 64. Cruz DN, Goh CY, Marenzi G, et al. Renal replacement thera-
pies for prevention of radiocontrast-induced nephropathy: a
47. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects systematic review. Am J Med. 2012;125(1):66-78.
in high-risk patients undergoing angiography. N Engl J Med.
2003;348:491. 65. Brigouri C, Visconti G, Focaccio A, et al for the REMEDIAL II
Investigators. Renal Insufficiency After Contrast Media
48. Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of Administration Trial II (REMEDIAL II): RenalGuard system
renal angiography: contrast media associated nephrotoxicity in high-risk patients for contrast-induced acute kidney injury.
and atheroembolism—a critical review. Am J Kidney Dis. Circulation. 2011;124:1260-1269.
1994;24:713.
66. Brater DC. Anti-inflammatory agents and renal function.
49. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast
media associated nephropathy: randomized comparison of Semin Arthritis Rheum. 2002;32(3 suppl 1):33.
2 hydration regimens in 1620 patients undergoing coronary 67. Breyer MD, Hao C, Qi Z. Cyclooxygenase-2 selective inhibitors
angioplasty. Arch Intern Med. 2002;162:329-336. and the kidney. Curr Opin Crit Care. 2001;7:393.
50. Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium 68. Linton AL, Clark WF, Driedger AA, et al. Acute interstitial
bicarbonate treatment regimens for the prevention of contrast- nephritis due to drugs: review of the literature with a report of
induced nephropathy. Ann Intern Med. 2009;151:631-638. nine cases. Ann Intern Med. 1980;93:735.
51. Tepel M, Van Der Giet M, Schwarzfeld C, et al. Prevention of 69. Nolan CR, Anger MS, Kelleher SP. Eosinophiluria: a new
radiographic-contrast-agent-induced reduction in renal func- method of detection and definition of the clinical spectrum.
tion by acetylcysteine. N Engl J Med. 2000;343:180. N Engl J Med. 1986;315:1516.
52. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute 70. Thadhani RI, Camargo CA Jr, Xavier RJ, et al. Atheroembolic
renal damage in patients with abnormal renal function under- renal failure after invasive procedures: natural history based on
going a coronary procedure. J Am Coll Cardiol. 2002;40:1383. 52 histologically proven cases. Medicine. 1995;74:350.

Section08-O-Ref.indd 2 12/10/2014 6:08:07 PM